EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Twenty-Two Years of Prenatal Testing for Suspected Monogenic Disorders: A Retrospective Single-Center Experience in Western Romania

Miruna Gug iD, Nicoleta Andreescu iD, Eugen Dan Chicea, Adrian Rațiu, Simona Farcaș, Ioana Marin iD, Stelian Țîcău, Cristina Gug iD

Medical Sciences · 2026

DOI: 10.3390/medsci14050548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, 2026. Verfasst von Miruna Gug und 7 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Genetic Testing, Genetic Diseases, Inborn. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Victor Babeș” University of Medicine and Pharmacy of Timișoara, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Prenatal testing strategies for suspected monogenic disorders have changed considerably over the past decades, alongside evolving referral indications and increasing availability of genomic technologies. Longitudinal, practice-based data describing these changes within routine clinical care remain limited, particularly in Central and Eastern Europe. We describe changes in referral indications, testing strategies, and molecular findings over 22 years in a single-center retrospective descriptive case series from Western Romania.

Methods

We conducted a retrospective analysis of 52 pregnancies investigated for suspected monogenic disorders between 2004 and 2026. Forty pregnancies were evaluated through a diagnostic pathway, while a separate group of 12 pregnancies underwent cell-free DNA (cfDNA)-based monogenic screening; these were analyzed as distinct clinical pathways. For the diagnostic pathway, clinical indications, testing strategies, and molecular findings were analyzed across three retrospectively defined study periods (2004–2013, 2014–2019, and 2020–2026).

Results

Within the diagnostic pathway, referral patterns shifted from predominantly family-history-based testing (55.6% of cases in 2004–2013) toward indications arising from positive parental carrier screening and fetal ultrasound abnormalities in later study periods. Testing strategies expanded from predominantly targeted single-gene testing and multiplex ligation-dependent probe amplification (MLPA) to include gene panels and whole-exome sequencing (WES). Among 34 pregnancies with fetal molecular evaluation, 7 (20.6%) had a confirmed disease-causing finding, 9 (26.5%) had carrier-only outcomes, 15 (44.1%) were classified as unaffected, and 3 (8.8%) had non-classic molecular findings. Incidental or additional molecular findings beyond the primary testing indication were identified in 6 of 34 pregnancies with fetal molecular evaluation (17.6%) and required case-specific interpretation and genetic counseling. The 12 cfDNA-based monogenic screening pregnancies constituted a separate, non-diagnostic screening pathway and were analyzed independently from the diagnostic pathway.

Conclusions

Over 22 years, referral indications for suspected monogenic disorders broadened alongside an expansion of prenatal testing strategies from predominantly targeted familial testing to a wider range of genomic approaches. These findings describe temporal changes within a single-center clinical practice and should not be interpreted as evidence that changes in testing strategy improved diagnostic performance or pregnancy outcomes. Invasive diagnostic testing and cfDNA-based monogenic screening represent distinct clinical pathways and should be interpreted separately.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prenatal DiagnosisGenetic TestingGenetic Diseases, InbornHumansFemalePregnancyRetrospective StudiesRomaniaAdultCell-Free Nucleic Acids

Stichwörter der Autor:innen

Romaniacell-free DNAgenetic counselingmedical geneticsmonogenic disordersprenatal diagnosisprenatal genomicswhole-exome sequencing

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Doctoral School of Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Discipline of Medical Genetics, Department of Microscopic Morphology, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.
  • Genomic Medicine Centre, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.
  • Regional Centre of Medical Genetics Timiș (CRGMT), "Louis Țurcanu" Clinical Emergency Hospital for Children, 300011 Timișoara, Romania.
  • Medical Genetics Office Doctor Gug, 300200 Timișoara, Romania.
  • Master's Program in Bioinformatics, Faculty of Informatics, West University of Timișoara, 300223 Timișoara, Romania.

ORCID-Profile: Miruna Gug, Nicoleta Andreescu, Ioana Marin, Cristina Gug

Förderung

  • “Victor Babeș” University of Medicine and Pharmacy of Timișoara, Romania

Zitieren

APA

Gug, M., Andreescu, N., Chicea, E. D., Rațiu, A., Farcaș, S., Marin, I., Țîcău, S., & Gug, C. (2026). Twenty-Two Years of Prenatal Testing for Suspected Monogenic Disorders: A Retrospective Single-Center Experience in Western Romania. Medical Sciences. https://doi.org/10.3390/medsci14050548

Vancouver

Gug M, Andreescu N, Chicea ED, Rațiu A, Farcaș S, Marin I, et al. Twenty-Two Years of Prenatal Testing for Suspected Monogenic Disorders: A Retrospective Single-Center Experience in Western Romania. Medical Sciences. 2026. doi:10.3390/medsci14050548

BibTeX
@article{Gug2026,
  author = {Gug, Miruna and Andreescu, Nicoleta and Chicea, Eugen Dan and Rațiu, Adrian and Farcaș, Simona and Marin, Ioana and Țîcău, Stelian and Gug, Cristina},
  title = {Twenty-Two Years of Prenatal Testing for Suspected Monogenic Disorders: A Retrospective Single-Center Experience in Western Romania},
  journal = {Medical Sciences},
  year = {2026},
  doi = {10.3390/medsci14050548}
}
Kostenlos starten →